Literature DB >> 4862333

The treatment of angina pectoris with a new beta-receptor blocking agent (H 56/28).

P Björntorp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4862333     DOI： 10.1111/j.0954-6820.1967.tb11525.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  8 in total

1.  [Modification of sympathetic hyperactivity by drugs. Short-term pharmacologic experiments using parasympathomimetics and beta-receptor blockaders in humans].

Authors:  A W von Eiff; A Czernik; K Zanders
Journal:  Klin Wochenschr       Date:  1969-07-01

2.  Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study.

Authors:  B J Sealey; J Liljedal; G Nyberg; B Ablad
Journal:  Br Heart J       Date:  1971-07

3.  Lidoflazine: double-blind trial of a new coronary vasodilator in angina pectoris.

Authors:  B Brantmark; N Egelius; E Fabricius; M Jemt; G Palmborg; J Philipson; N Rönnegård
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

Review 4.  Beta-adrenergic receptor blocking drugs in angina pectoris.

Authors:  B N Prichard
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.

Authors:  I Nordenfelt; L Olsson; S Persson
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

6.  Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.

Authors:  A Aubert; G Nyberg; R Slaastad; L Tjeldflaat
Journal:  Br Med J       Date:  1970-01-24

7.  Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

Authors:  A G Wilson; O G Brooke; H J Lloyd; B F Robinson
Journal:  Br Med J       Date:  1969-11-15

8.  Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.

Authors:  J R Parratt; R M Wadsworth
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.